ICAAC in San Diego 2015

Ron Dagan, Professor of Pediatrics and Infectious Diseases at the Pediatric Infectious Disease Unit, Soroka University Medical Center, Israel discusses his research that showed how the introduction of both pneumococcal conjugate vaccines and rotavirus vaccines led to the rapid and dramatic reduction in hospital burden of both winter diarrhea and respiratory infections within 5 years post introduction of the vaccines.
Nishal Govindji-Bhatt, Post-doctoral Research Associate at the University of Manchester, United Kingdom, and Curtis Dobson, PhD, University of Manchester, discuss how to best avoid eye infection caused by poor contact lens case cleaning.
Vytas Karalius, Medical Student at Mayo Medical School, Mayo Clinic, and Dr. Robin Patel, director of the Infectious Diseases Research Laboratory at Mayo Clinic discuss an outbreak of Bordetella parapertussis in Southeastern Minnesota and examine the efficacy of the vaccine against different species of B. pertussis.
Dr. Sally Hodder, Director of the West Virginia Clinical and Translational Science Institute, will share the results from WAVES, the First International Phase 3 HIV Study to Enroll Only Women.
Meriam Memmi, PhD candidate at University Jean Monnet of Saint-Etienne, France discusses her research which led the creation of a new birth control device with additional protective properties against sexually transmitted infections (STIs)
Jessica Galloway-Peña, Ph.D., fellow in the Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center and her colleagues have shown that disruption of the microbiome by illness or the administration of therapeutics can often lead to detrimental effects in immunocompromised cancer patients.
Maggie Monogue, Clinical Pharmacy Fellow at Hartford Hospital Center for Anti-Infective Research and Development and her colleague Jessica Ortwine, PharmD., Clinical Infectious Disease Pharmacist at Parkland Health and Hospital System, discuss their research comparing clinical outcomes between patients receiving nafcillin and cefazolin for treatment of MSSA bacterium.